VAEY
DEAD

Serial Number

87096970

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 8, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VAEY Trademark

Serial Number: 87096970

VAEY is a trademark filed by NOVARTIS AG on July 8, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 8, 2016

Registration Date

Not Registered

Published for Opposition

October 25, 2016

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 22, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 22, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2018 EXRA
SOU EXTENSION 4 GRANTED
Dec 19, 2018 EX4G
SOU EXTENSION 4 FILED
Dec 19, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 19, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jun 19, 2018 EX3G
SOU EXTENSION 3 FILED
Jun 19, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 19, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2017 EXRA
SOU EXTENSION 2 GRANTED
Dec 18, 2017 EX2G
SOU EXTENSION 2 FILED
Dec 18, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 18, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jun 7, 2017 EX1G
SOU EXTENSION 1 FILED
Jun 7, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 7, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2016 CNSA
ASSIGNED TO EXAMINER
Sep 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2016 NWOS
NEW APPLICATION ENTERED
Jul 12, 2016 NWAP